⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78418 | 0.67 | — | — | |
| SCHEMBL2241586 | 0.61 | — | — | |
| SCHEMBL2241592 | 0.61 | — | — | |
| SCHEMBL15510742 | 0.54 | — | — | |
| SCHEMBL5318324 | 0.54 | — | — | |
| SCHEMBL517175 | 0.51 | — | — | |
| SCHEMBL23964 | 0.51 | — | — | |
| SCHEMBL6517038 | 0.45 | — | — | |
| SCHEMBL18886880 | 0.45 | — | — | |
| SCHEMBL59324 | 0.45 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023247593-A1 | PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2023-12-28 | — | — | WO | claimed |
| EP-4284797-A1 | PYRAZOLEAMIDE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-12-06 | — | — | EP | claimed |
| US-20230382911-A1 | PYRAZOLEAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-11-30 | — | — | US | claimed |
| US-20230322695-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY | 2023-10-12 | — | — | US | claimed |
| CN-116867782-A | Pyrazole amide derivative | 豪夫迈·罗氏有限公司 | 2023-10-10 | — | — | CN | claimed |
| WO-2023147531-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-08-03 | — | — | WO | claimed |
| WO-2023036821-A1 | NEW QUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2023-03-16 | — | — | WO | claimed |
| EP-4148052-A1 | NEW QUINOLINE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2023-03-15 | — | — | EP | claimed |
| WO-2014015934-A1 | HYDROXYSTATIN DERIVATIVES FOR TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2014-01-30 | — | — | WO | claimed |
| EP-2673287-A1 | AMINO STATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2013-12-18 | — | — | EP | claimed |
| EP-2670406-A1 | COMBINATION THERAPY WITH INTERFERON AND ANDROGRAPHOLIDES FOR MULTIPLE SCLEROSIS | Herbal Powers Corporation (US) | 2013-12-11 | — | — | EP | claimed |
| WO-2013096423-A1 | COMBINATION THERAPY WITH INTERFERON AND ANDROGRAPHOLIDES FOR MULTIPLE SCLEROSIS | Herbal Powers Corporation (US) | 2013-06-27 | — | — | WO | claimed |
| WO-2012107153-A1 | AMINO STATIN DERIVATIVESFOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2012-08-16 | — | — | WO | claimed |
| EP-1890543-A1 | INCREASE OF STRESS TOLERANCE BY APPLICATION OF NEONICOTINOIDS ON PLANTS ENGINEERED TO BE STRESS TOLERANT | Bayer CropScience Aktiengesellschaft (DE) | 2008-02-27 | — | — | EP | claimed |
| CN-101076515-A | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | HOFFMANN LA ROCHE (CH) | 2007-11-21 | — | — | CN | claimed |
| WO-2006131222-A1 | INCREASE OF STRESS TOLERANCE BY APPLICATION OF NEONICOTINOIDS ON PLANTS ENGINEERED TO BE STRESS TOLERANT | BAYER CROPSCIENCE AG (DE) | 2006-12-14 | — | — | WO | claimed |
| CN-1553897-A | Dolastatin 10 derivatives | - | 2004-12-08 | — | — | CN | claimed |
| EP-0004435-A2 | Ethers of 4-halomethylpyridines, fungicidal compositions and method for protecting plants from fungal disease | THE DOW CHEMICAL COMPANY (US) | 1979-10-03 | — | — | EP | claimed |